Videos 1 - 10 for drug identification
NOTICE: These results are from cnbc.com only. To expand your search, click show all videos.
9 months agoA new medical study could result in millions of Americans being put on a cholesterol-lowering drug, reports CNBC's Mike Huckman. cnbc.com more open pop
1 year agoA big pharma survival guide, with Jeffrey Kraws, Crystal Research Associates sr. pharmaceutical analyst; Les Funtleyder, Miller Tabak pharma analyst and CNBC's Joe Kernen. cnbc.com more open pop
9 months agoInsight on the pharmaceutical company's outlook and why the stock hasn't performed better, with Kenneth Frazier, Merck senior vice president/general counsel, and CNBC's Mike ... cnbc.com more open pop
9 months agoThe US Supreme Court begins hearing a landmark case Monday that has major implications for the drug industry, reports CNBC's Hampton Pearson. cnbc.com more open pop
9 months agoBig generic drug makers, like Teva, have been outperforming in the broader market. Insight with William Marth, Teva North America CEO & CNBC's Mike Huckman. cnbc.com more open pop
1 year agoLooking at solutions to fix the Food & Drug Administration, Medicare and more, witih Mark McClellan, Brookings Institution sr. fellow & former FDA commissioner and CNBC's ... cnbc.com more open pop
9 months agoThe world's biggest drug company makes an acquisition in the biotech field, with CNBC's Mike Huckman. cnbc.com more open pop
9 months agoA look at the big picture of retail sales, Andrew Wolf, BB&T Capital Marketsfood/ drug/retail sector analyst. cnbc.com more open pop
9 months agoPharmaceuticals may not be that defensive, including pharmaceuticals, with CNBC's Mike Huckman, and a review of yesterday's poll results on trading in a volatile market. cnbc.com more open pop
9 months agoCramer thinks Forest Labs is insanely cheap for a well managed drug company with a solid pipeline. cnbc.com more open pop
|
|
